ABUS stock · NET stock

ABUS vs NET

Arbutus Biopharma Corp (ABUS) versus Cloudflare Inc (NET) — a side-by-side from cached financials, not a winner call.

Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.

Cloudflare Inc (NET) is a software - infrastructure company listed on NYSE. It is led by Matthew Prince.

Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.

Latest reported NET revenue for 2025-12-31 was $2.17B. Net income was -$102.3M. Revenue was up 29.8% from 2024-12-31 to 2025-12-31. NET currently screens at market cap $80.53B.

ABUS currently screens at market cap $883.0M and trailing P/E 5.4. NET currently screens at market cap $80.53B.

Not investment advice. Open the ABUS and NET stock pages for the full models.

Not investment advice.

Popular Stock Comparisons